{
    "code": "01052530",
    "url": "https:\/\/info.fda.gov.tw\/MLMS\/H0001D.aspx?Type=Lic&LicId=01052530",
    "time": "2021-03-19 03:01:21",
    "許可證字號": "衛署藥製字第052530號",
    "註銷狀態": "",
    "註銷日期": "",
    "註銷理由": "",
    "製造許可登錄編號": "",
    "有效日期": "114\/02\/26",
    "發證日期": "99\/02\/26",
    "許可證種類": "製　劑",
    "舊證字號": "",
    "醫療器材級數": "",
    "通關簽審文件編號": "DHY00105253006",
    "中文品名": "降脂妥膜衣錠 20 毫克",
    "英文品名": "Atorin F.C. Tablets 20mg",
    "適應症": "高膽固醇血症、高三酸甘油脂血症。對於臨床上沒有冠心病的第二型糖尿病患者，但是至少有任一其他冠心病危險因子，包括高血壓、視網膜病變、白蛋白尿、或吸菸，Atorvastatin適用於：降低心肌梗塞的風險、降低中風的風險。降低冠心病高危險群的心血管事件發生率對於臨床上沒有冠心病的高血壓患者，但是至少有三個其他冠心病危險因子，包括第二型糖尿病、年紀大於等於55歲、微白蛋白尿或蛋白尿、吸煙、或第一等親在55歲(男性)或60歲(女性)前曾經發生冠心病事件，Atorvastatin適用於：降低心肌梗塞的風險、降低中風的風險、降低血管再造術與心絞痛的風險。",
    "劑型": "116膜衣錠",
    "包裝": "2~1000錠鋁箔盒裝 2~1000錠塑膠瓶裝",
    "儲存溫度": "",
    "有效期間": "",
    "指示藥品審查基準": "",
    "標籤、仿單及包裝加註": "",
    "藥品類別": "06須由醫師處方使用",
    "管制藥品分類級別": "",
    "藥品分類": "",
    "監視期限": "",
    "主成分略述": "ATORVASTATIN (CALCIUM)",
    "限制項目": "01國　產 24監視期滿學名藥 62完成溶離率試驗",
    "申請商名稱": "1119206200  健亞生物科技股份有限公司",
    "申請商地址": "新竹縣湖口鄉中興村工業一路１號",
    "主製造廠": [
        {
            "製造廠名稱": "1119206300  健亞生物科技股份有限公司",
            "製造廠廠址": "新竹縣湖口鄉新竹工業區工業一路１號",
            "製造廠公司地址": "",
            "製造廠國別": "TAIWAN",
            "製程": ""
        }
    ],
    "CCC號列": "",
    "藥理治療分類": "",
    "ingredients": [
        {
            "成分類別": "主成分",
            "成分代碼": "2406003120",
            "成分名稱": "ATORVASTATIN (CALCIUM)",
            "含量描述": "",
            "含量": "20.0000000000",
            "單位": "MG"
        }
    ],
    "藥物辨識詳細資料": {
        "外觀尺寸": "",
        "特殊劑型": "",
        "顏色": "",
        "特殊氣味": "",
        "刻痕": "",
        "形狀": "",
        "標記一": "",
        "標記二": ""
    },
    "藥物辨識外觀圖片": [
        {
            "title": "010525300001-104-09-15(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=01052530&Seq=001&Type=10"
        }
    ],
    "仿單外盒": [
        {
            "title": "20201007新降脂妥仿單20-109-11-02.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=01052530&Seq=010&Type=9"
        },
        {
            "title": "20201007新降脂妥仿單20-109-10-27.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=01052530&Seq=009&Type=9"
        },
        {
            "title": "冠億-降脂妥膜衣錠20 40毫克 103 08 反面 0808A-104-09-30(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=01052530&Seq=008&Type=9"
        },
        {
            "title": "Label-Atorin F.C.T 20mg-109-11-02.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=01052530&Seq=010&Type=8"
        },
        {
            "title": "Atorin F.C.T 20mg-Insert正面-109-10-27.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=01052530&Seq=009&Type=8"
        },
        {
            "title": "Atorin F.C.T 20mg-Insert反面-109-10-27.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=01052530&Seq=008&Type=8"
        },
        {
            "title": "Atorin F.C.T 20mg-Carton-109-10-27.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=01052530&Seq=007&Type=8"
        },
        {
            "title": "Atorin F.C.T 20mg-Alumi. Foil-109-10-27.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=01052530&Seq=006&Type=8"
        },
        {
            "title": "CN264A2 Atorin 20mg 28's 上下點膠-104-09-15(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=01052530&Seq=005&Type=8"
        }
    ]
}